Company news

TELA Bio, Inc. news in 2021

TELA Bio, Inc.'s news releases, calls and decks from 2021, newest first.

View company

TELA Bio Reports Strong Third Quarter 2021 Revenues Reflecting Continued Growth Driven by Increased Demand

November 9, 2021

TELA Bio Announces Publication of 12-Month Results from the BRAVO Study with Continued Positive Outcomes Through 24 months

November 8, 2021

TELA Bio and Next Science Enter into Exclusive Distribution Agreement in the Plastic Reconstructive Market for Advanced Anti-Biofilm Surgical Wash

October 31, 2021

TELA Bio Appoints Roberto Cuca as Chief Operating Officer and Chief Financial Officer

September 26, 2021

TELA Bio® Announces New Data on Use of OviTex in a Range of Hernia Repair Applications, Including Novel ReBAR (Reinforced Biologic Augmented Repair) Technique

September 12, 2021

TELA Bio's OviTex® Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021

August 15, 2021

TELA Bio Reports Record Second Quarter 2021 Revenues Driven by Increased Demand

August 10, 2021

TELA Bio to Announce Second Quarter 2021 Financial Results

July 27, 2021

TELA Bio Announces Changes to its Board of Directors

June 1, 2021

TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs

May 24, 2021

TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias

May 18, 2021

TELA Bio Announces First Quarter 2021 Financial Results

May 12, 2021

TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results

March 23, 2021

TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair

March 17, 2021

TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021

March 1, 2021

TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020

January 13, 2021

TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development

January 4, 2021

Calls in 2021

Decks in 2021